{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:12:16Z","timestamp":1794654736572,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Loss of bone is a common medical problem and, while it can be treated with available therapies, some of these therapies have critical side effects. We have previously demonstrated that CGS21680, a selective A<jats:sub>2A<\/jats:sub> adenosine receptor agonist, prevents bone loss, but its on-target toxicities (hypotension, tachycardia) and frequent dosing requirements make it unusable in the clinic. We therefore generated a novel alendronate-CGS21680 conjugate (MRS7216), to target the agonist to bone where it remains for long periods thereby diminishing the frequency of administration and curtailing side effects. MRS7216 was synthesized from CGS21680 by sequential activation of the carboxylic acid moiety and reacting with an appropriate amino acid (PEG, alendronic acid) under basic conditions. MRS7216 was tested on C57BL\/6J (WT) mice with established osteoporosis (OP) and WT or A2A KO mice with wear particle-induced inflammatory osteolysis (OL). Mice were treated weekly with MRS7216 (10mg\/kg). Bone formation was studied after in vivo labeling with calcein\/Alizarin Red, and \u03bcCT and histology analyses were performed. In addition, human primary osteoblasts and osteoclasts were cultured using bone marrow discarded after hip replacement. Receptor binding studies demonstrate that MRS7216 efficiently binds the A2A adenosine receptor. MRS7216-treated OP and OL mice had significant new bone formation and reduced bone loss compared to vehicle or alendronate-treated mice. Histological analysis showed that MRS7216 treatment significantly reduced osteoclast number and increased osteoblast number in murine models. Interestingly, cultured human osteoclast differentiation was inhibited, and osteoblast differentiation was stimulated by the compound indicating that MRS7216 conjugates represent a novel therapeutic approach to treat osteoporosis and osteolysis.<\/jats:p>","DOI":"10.1186\/s13075-022-02961-0","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T05:03:05Z","timestamp":1670562185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Novel alendronate-CGS21680 conjugate reduces bone resorption and induces new bone formation in post-menopausal osteoporosis and inflammatory osteolysis mouse models"],"prefix":"10.1186","volume":"24","author":[{"given":"Ane","family":"Larra\u00f1aga-Vera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran S.","family":"Toti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Flatow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J.","family":"Haraczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Warnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsha","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-Guo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aranzazu","family":"Mediero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce N.","family":"Cronstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"key":"2961_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-3-319-51284-6_6","volume":"55","author":"WE Muller","year":"2017","unstructured":"Muller WE, Wang X, Schroder HC. New target sites for treatment of osteoporosis. Prog Mol Subcell Biol. 2017;55:187\u2013219.","journal-title":"Prog Mol Subcell Biol"},{"issue":"2","key":"2961_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/03008207.2017.1290085","volume":"59","author":"X Chen","year":"2018","unstructured":"Chen X, Wang Z, Duan N, Zhu G, Schwarz EM, Xie C. Osteoblast-osteoclast interactions. Connect Tissue Res. 2018;59(2):99\u2013107.","journal-title":"Connect Tissue Res"},{"issue":"7","key":"2961_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.4158\/EP161678.RA","volume":"23","author":"SG Albert","year":"2017","unstructured":"Albert SG, Reddy S. Clinical evaluation of cost efficacy of drugs for treatment of osteoporosis: a meta-analysis. Endocr Pract. 2017;23(7):841\u201356.","journal-title":"Endocr Pract"},{"issue":"9","key":"2961_CR4","doi-asserted-by":"publisher","first-page":"8046","DOI":"10.1016\/j.actbio.2013.05.005","volume":"9","author":"J Gallo","year":"2013","unstructured":"Gallo J, Goodman SB, Konttinen YT, Wimmer MA, Holinka M. Osteolysis around total knee arthroplasty: a review of pathogenetic mechanisms. Acta Biomater. 2013;9(9):8046\u201358.","journal-title":"Acta Biomater"},{"issue":"8","key":"2961_CR5","doi-asserted-by":"publisher","first-page":"5696","DOI":"10.1002\/jcp.26465","volume":"233","author":"JW Vargas-Franco","year":"2018","unstructured":"Vargas-Franco JW, Castaneda B, Redini F, Gomez DF, Heymann D, Lezot F. Paradoxical side effects of bisphosphonates on the skeleton: What do we know and what can we do? J Cell Physiol. 2018;233(8):5696\u2013715.","journal-title":"J Cell Physiol"},{"issue":"6","key":"2961_CR6","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/joim.12339","volume":"277","author":"IR Reid","year":"2015","unstructured":"Reid IR. Efficacy, effectiveness and side effects of medications used to prevent fractures. J Intern Med. 2015;277(6):690\u2013706.","journal-title":"J Intern Med"},{"issue":"2","key":"2961_CR7","doi-asserted-by":"publisher","first-page":"R145","DOI":"10.1530\/JME-18-0173","volume":"62","author":"TD Rachner","year":"2019","unstructured":"Rachner TD, Hofbauer LC, Gobel A, Tsourdi E. Novel therapies in osteoporosis: PTH-related peptide analogs and inhibitors of sclerostin. J Mol Endocrinol. 2019;62(2):R145\u201354.","journal-title":"J Mol Endocrinol"},{"issue":"1","key":"2961_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.afos.2018.03.002","volume":"4","author":"MR McClung","year":"2018","unstructured":"McClung MR. Romosozumab for the treatment of osteoporosis. Osteoporos Sarcopenia. 2018;4(1):11\u20135.","journal-title":"Osteoporos Sarcopenia"},{"issue":"7","key":"2961_CR9","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1161\/ATVBAHA.119.312371","volume":"39","author":"K Asadipooya","year":"2019","unstructured":"Asadipooya K, Weinstock A. Cardiovascular Outcomes of Romosozumab and Protective Role of Alendronate. Arterioscler Thromb Vasc Biol. 2019;39(7):1343\u201350.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2961_CR10","doi-asserted-by":"publisher","first-page":"780","DOI":"10.2106\/00004623-200704000-00012","volume":"89","author":"S Kurtz","year":"2007","unstructured":"Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780\u20135.","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"2961_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00402-015-2196-8","volume":"135","author":"K Magone","year":"2015","unstructured":"Magone K, Luckenbill D, Goswami T. Metal ions as inflammatory initiators of osteolysis. Arch Orthop Trauma Surg. 2015;135(5):683\u201395.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"14","key":"2961_CR12","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.biomaterials.2004.06.010","volume":"26","author":"M von Knoch","year":"2005","unstructured":"von Knoch M, Wedemeyer C, Pingsmann A, von Knoch F, Hilken G, Sprecher C, et al. The decrease of particle-induced osteolysis after a single dose of bisphosphonate. Biomaterials. 2005;26(14):1803\u20138.","journal-title":"Biomaterials"},{"issue":"1","key":"2961_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrrheum.2016.178","volume":"13","author":"BN Cronstein","year":"2017","unstructured":"Cronstein BN, Sitkovsky M. Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases. Nat Rev Rheumatol. 2017;13(1):41\u201351.","journal-title":"Nat Rev Rheumatol"},{"issue":"135","key":"2961_CR14","doi-asserted-by":"publisher","first-page":"135ra165","DOI":"10.1126\/scitranslmed.3003393","volume":"4","author":"A Mediero","year":"2012","unstructured":"Mediero A, Frenkel SR, Wilder T, He W, Mazumder A, Cronstein BN. Adenosine A2A receptor activation prevents wear particle-induced osteolysis. Sci Transl Med. 2012;4(135):135ra165.","journal-title":"Sci Transl Med"},{"issue":"2","key":"2961_CR15","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/jbm.b.33561","volume":"105","author":"S Ishack","year":"2017","unstructured":"Ishack S, Mediero A, Wilder T, Ricci JL, Cronstein BN. Bone regeneration in critical bone defects using three-dimensionally printed beta-tricalcium phosphate\/hydroxyapatite scaffolds is enhanced by coating scaffolds with either dipyridamole or BMP-2. J Biomed Mater Res B Appl Biomater. 2017;105(2):366\u201375.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"2","key":"2961_CR16","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ajpath.2011.10.017","volume":"180","author":"A Mediero","year":"2012","unstructured":"Mediero A, Kara FM, Wilder T, Cronstein BN. Adenosine A(2A) receptor ligation inhibits osteoclast formation. Am J Pathol. 2012;180(2):775\u201386.","journal-title":"Am J Pathol"},{"issue":"1","key":"2961_CR17","doi-asserted-by":"publisher","first-page":"18439","DOI":"10.1038\/s41598-019-54726-6","volume":"9","author":"MM Wang","year":"2019","unstructured":"Wang MM, Flores RL, Witek L, Torroni A, Ibrahim A, Wang Z, et al. Dipyridamole-loaded 3D-printed bioceramic scaffolds stimulate pediatric bone regeneration in vivo without disruption of craniofacial growth through facial maturity. Sci Rep. 2019;9(1):18439.","journal-title":"Sci Rep"},{"issue":"11","key":"2961_CR18","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1096\/fj.201600616R","volume":"30","author":"A Mediero","year":"2016","unstructured":"Mediero A, Wilder T, Reddy VS, Cheng Q, Tovar N, Coelho PG, et al. Ticagrelor regulates osteoblast and osteoclast function and promotes bone formation in vivo via an adenosine-dependent mechanism. FASEB J. 2016;30(11):3887\u2013900.","journal-title":"FASEB J"},{"issue":"2","key":"2961_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jcms.2017.11.011","volume":"46","author":"JM Bekisz","year":"2018","unstructured":"Bekisz JM, Flores RL, Witek L, Lopez CD, Runyan CM, Torroni A, et al. Dipyridamole enhances osteogenesis of three-dimensionally printed bioactive ceramic scaffolds in calvarial defects. J Craniomaxillofac Surg. 2018;46(2):237\u201344.","journal-title":"J Craniomaxillofac Surg"},{"key":"2961_CR20","doi-asserted-by":"crossref","unstructured":"Lopez CD, Bekisz JM, Corciulo C, Mediero A, Coelho PG, Witek L, et al. Local delivery of adenosine receptor agonists to promote bone regeneration and defect healing. Adv Drug Deliv Rev. 2018;146:240\u20137.","DOI":"10.1016\/j.addr.2018.06.010"},{"key":"2961_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jss.2017.10.027","volume":"223","author":"CD Lopez","year":"2018","unstructured":"Lopez CD, Diaz-Siso JR, Witek L, Bekisz JM, Cronstein BN, Torroni A, et al. Three dimensionally printed bioactive ceramic scaffold osseoconduction across critical-sized mandibular defects. J Surg Res. 2018;223:115\u201322.","journal-title":"J Surg Res"},{"issue":"5","key":"2961_CR22","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1097\/PRS.0000000000005531","volume":"143","author":"CD Lopez","year":"2019","unstructured":"Lopez CD, Diaz-Siso JR, Witek L, Bekisz JM, Gil LF, Cronstein BN, et al. Dipyridamole augments three-dimensionally printed bioactive ceramic scaffolds to regenerate craniofacial bone. Plast Reconstr Surg. 2019;143(5):1408\u201319.","journal-title":"Plast Reconstr Surg"},{"issue":"13","key":"2961_CR23","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/bdr2.1345","volume":"110","author":"CD Lopez","year":"2018","unstructured":"Lopez CD, Witek L, Torroni A, Flores RL, Demissie DB, Young S, et al. The role of 3D printing in treating craniomaxillofacial congenital anomalies. Birth Defects Res. 2018;110(13):1055\u201364.","journal-title":"Birth Defects Res"},{"issue":"9","key":"2961_CR24","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1002\/term.2733","volume":"12","author":"N Tovar","year":"2018","unstructured":"Tovar N, Witek L, Atria P, Sobieraj M, Bowers M, Lopez CD, et al. Form and functional repair of long bone using 3D-printed bioactive scaffolds. J Tissue Eng Regen Med. 2018;12(9):1986\u201399.","journal-title":"J Tissue Eng Regen Med"},{"issue":"12","key":"2961_CR25","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/jor.24424","volume":"37","author":"L Witek","year":"2019","unstructured":"Witek L, Alifarag AM, Tovar N, Lopez CD, Cronstein BN, Rodriguez ED, et al. Repair of critical-sized long bone defects using dipyridamole-augmented 3D-printed bioactive ceramic scaffolds. J Orthop Res. 2019;37(12):2499\u2013507.","journal-title":"J Orthop Res"},{"issue":"3","key":"2961_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0014-2999(02)01305-5","volume":"438","author":"JR Fozard","year":"2002","unstructured":"Fozard JR, Ellis KM, Villela Dantas MF, Tigani B, Mazzoni L. Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat. Eur J Pharmacol. 2002;438(3):183\u20138.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"2961_CR27","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.pbb.2008.01.006","volume":"89","author":"S Mingote","year":"2008","unstructured":"Mingote S, Pereira M, Farrar AM, McLaughlin PJ, Salamone JD. Systemic administration of the adenosine A(2A) agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intake. Pharmacol Biochem Behav. 2008;89(3):345\u201351.","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"2961_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2165\/00044011-200525020-00003","volume":"25","author":"KC Lasseter","year":"2005","unstructured":"Lasseter KC, Porras AG, Denker A, Santhanagopal A, Daifotis A. Pharmacokinetic considerations in determining the terminal elimination half-lives of bisphosphonates. Clin Drug Investig. 2005;25(2):107\u201314.","journal-title":"Clin Drug Investig"},{"issue":"6","key":"2961_CR29","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.bone.2011.03.720","volume":"48","author":"YX He","year":"2011","unstructured":"He YX, Zhang G, Pan XH, Liu Z, Zheng LZ, Chan CW, et al. Impaired bone healing pattern in mice with ovariectomy-induced osteoporosis: A drill-hole defect model. Bone. 2011;48(6):1388\u2013400.","journal-title":"Bone"},{"issue":"8","key":"2961_CR30","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1359\/jbmr.070507","volume":"22","author":"V Glatt","year":"2007","unstructured":"Glatt V, Canalis E, Stadmeyer L, Bouxsein ML. Age-related changes in trabecular architecture differ in female and male C57BL\/6J mice. J Bone Miner Res. 2007;22(8):1197\u2013207.","journal-title":"J Bone Miner Res"},{"key":"2961_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jot.2020.03.001","volume":"26","author":"Y Yang","year":"2021","unstructured":"Yang Y, Liu Q, Zhang L, Fu X, Chen J, Hong D. A modified tape transfer approach for rapidly preparing high-quality cryosections of undecalcified adult rodent bones. J Orthop Translat. 2021;26:92\u2013100.","journal-title":"J Orthop Translat"},{"issue":"2","key":"2961_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/jbm4.10027","volume":"2","author":"AB Khalid","year":"2018","unstructured":"Khalid AB, Slayden AV, Kumpati J, Perry CD, Osuna MAL, Arroyo SR, et al. GATA4 directly regulates Runx2 expression and osteoblast differentiation. JBMR Plus. 2018;2(2):81\u201391.","journal-title":"JBMR Plus"},{"issue":"9","key":"2961_CR33","first-page":"3109","volume":"85","author":"RP Tonino","year":"2000","unstructured":"Tonino RP, Meunier PJ, Emkey R, Rodriguez-Portales JA, Menkes CJ, Wasnich RD, et al. Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group. J Clin Endocrinol Metab. 2000;85(9):3109\u201315.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2961_CR34","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1111\/bph.12227","volume":"169","author":"A Mediero","year":"2013","unstructured":"Mediero A, Perez-Aso M, Cronstein BN. Activation of adenosine A(2A) receptor reduces osteoclast formation via PKA- and ERK1\/2-mediated suppression of NFkappaB nuclear translocation. Br J Pharmacol. 2013;169(6):1372\u201388.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"2961_CR35","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1096\/fj.14-265066","volume":"29","author":"A Mediero","year":"2015","unstructured":"Mediero A, Wilder T, Perez-Aso M, Cronstein BN. Direct or indirect stimulation of adenosine A2A receptors enhances bone regeneration as well as bone morphogenetic protein-2. FASEB J. 2015;29(4):1577\u201390.","journal-title":"FASEB J"},{"issue":"6","key":"2961_CR36","doi-asserted-by":"publisher","first-page":"7555","DOI":"10.1096\/fj.201900014R","volume":"33","author":"S Borhani","year":"2019","unstructured":"Borhani S, Corciulo C, Larranaga-Vera A, Cronstein BN. Adenosine A2A receptor (A2AR) activation triggers Akt signaling and enhances nuclear localization of beta-catenin in osteoblasts. FASEB J. 2019;33(6):7555\u201362.","journal-title":"FASEB J"},{"issue":"7","key":"2961_CR37","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1096\/fj.201700217R","volume":"32","author":"A Mediero","year":"2018","unstructured":"Mediero A, Wilder T, Shah L, Cronstein BN. Adenosine A2A receptor (A2AR) stimulation modulates expression of semaphorins 4D and 3A, regulators of bone homeostasis. FASEB J. 2018;32(7):3487\u2013501.","journal-title":"FASEB J"},{"issue":"10","key":"2961_CR38","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/jor.20620","volume":"26","author":"R Tsutsumi","year":"2008","unstructured":"Tsutsumi R, Hock C, Bechtold CD, Proulx ST, Bukata SV, Ito H, et al. Differential effects of biologic versus bisphosphonate inhibition of wear debris-induced osteolysis assessed by longitudinal micro-CT. J Orthop Res. 2008;26(10):1340\u20136.","journal-title":"J Orthop Res"},{"issue":"2","key":"2961_CR39","first-page":"1849","volume":"18","author":"T Geng","year":"2018","unstructured":"Geng T, Chen X, Zheng M, Yu H, Zhang S, Sun S, et al. Effects of strontium ranelate on wear particle induced aseptic loosening in female ovariectomized mice. Mol Med Rep. 2018;18(2):1849\u201357.","journal-title":"Mol Med Rep"},{"issue":"9","key":"2961_CR40","doi-asserted-by":"publisher","first-page":"e7414","DOI":"10.1590\/1414-431x20187414","volume":"51","author":"T Geng","year":"2018","unstructured":"Geng T, Sun S, Yu H, Guo H, Zheng M, Zhang S, et al. Strontium ranelate inhibits wear particle-induced aseptic loosening in mice. Braz J Med Biol Res. 2018;51(9):e7414.","journal-title":"Braz J Med Biol Res"},{"issue":"3","key":"2961_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2302\/kjm.54.127","volume":"54","author":"BF Boyce","year":"2005","unstructured":"Boyce BF, Li P, Yao Z, Zhang Q, Badell IR, Schwarz EM, et al. TNF-alpha and pathologic bone resorption. Keio J Med. 2005;54(3):127\u201331.","journal-title":"Keio J Med"},{"issue":"9","key":"2961_CR42","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1002\/art.21236","volume":"52","author":"Q Zhang","year":"2005","unstructured":"Zhang Q, Badell IR, Schwarz EM, Boulukos KE, Yao Z, Boyce BF, et al. Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2. Arthritis Rheum. 2005;52(9):2708\u201318.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2961_CR43","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1002\/jcp.23001","volume":"227","author":"M Takedachi","year":"2012","unstructured":"Takedachi M, Oohara H, Smith BJ, Iyama M, Kobashi M, Maeda K, et al. CD73-generated adenosine promotes osteoblast differentiation. J Cell Physiol. 2012;227(6):2622\u201331.","journal-title":"J Cell Physiol"},{"issue":"8","key":"2961_CR44","doi-asserted-by":"publisher","first-page":"eaax1387","DOI":"10.1126\/sciadv.aax1387","volume":"5","author":"YV Shih","year":"2019","unstructured":"Shih YV, Liu M, Kwon SK, Iida M, Gong Y, Sangaj N, et al. Dysregulation of ectonucleotidase-mediated extracellular adenosine during postmenopausal bone loss. Sci Adv. 2019;5(8):eaax1387.","journal-title":"Sci Adv"},{"issue":"11","key":"2961_CR45","doi-asserted-by":"publisher","first-page":"e0188135","DOI":"10.1371\/journal.pone.0188135","volume":"12","author":"JL Feig","year":"2017","unstructured":"Feig JL, Mediero A, Corciulo C, Liu H, Zhang J, Perez-Aso M, et al. The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin. PLoS One. 2017;12(11):e0188135.","journal-title":"PLoS One"},{"issue":"6","key":"2961_CR46","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.tem.2013.02.001","volume":"24","author":"A Mediero","year":"2013","unstructured":"Mediero A, Cronstein BN. Adenosine and bone metabolism. Trends Endocrinol Metab. 2013;24(6):290\u2013300.","journal-title":"Trends Endocrinol Metab"},{"issue":"11","key":"2961_CR47","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1096\/fj.14-255703","volume":"28","author":"A Mediero","year":"2014","unstructured":"Mediero A, Perez-Aso M, Cronstein BN. Activation of EPAC1\/2 is essential for osteoclast formation by modulating NFkappaB nuclear translocation and actin cytoskeleton rearrangements. FASEB J. 2014;28(11):4901\u201313.","journal-title":"FASEB J"},{"issue":"4","key":"2961_CR48","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s10753-018-0781-z","volume":"41","author":"JM Bekisz","year":"2018","unstructured":"Bekisz JM, Lopez CD, Corciulo C, Mediero A, Coelho PG, Witek L, et al. The role of adenosine receptor activation in attenuating cartilaginous inflammation. Inflammation. 2018;41(4):1135\u201341.","journal-title":"Inflammation"},{"key":"2961_CR49","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.neuropharm.2018.02.035","volume":"139","author":"JL Carlin","year":"2018","unstructured":"Carlin JL, Jain S, Duroux R, Suresh RR, Xiao C, Auchampach JA, et al. Activation of adenosine A2A or A2B receptors causes hypothermia in mice. Neuropharmacology. 2018;139:268\u201378.","journal-title":"Neuropharmacology"},{"issue":"6643","key":"2961_CR50","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/41771","volume":"388","author":"C Ledent","year":"1997","unstructured":"Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ, et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature. 1997;388(6643):674\u20138.","journal-title":"Nature"},{"key":"2961_CR51","first-page":"18","volume":"101","author":"JH Lin","year":"1999","unstructured":"Lin JH, Russell G, Gertz B. Pharmacokinetics of alendronate: an overview. Int J Clin Pract Suppl. 1999;101:18\u201326.","journal-title":"Int J Clin Pract Suppl"},{"issue":"5","key":"2961_CR52","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.tice.2017.07.001","volume":"49","author":"V Bradaschia-Correa","year":"2017","unstructured":"Bradaschia-Correa V, Josephson AM, Egol AJ, Mizrahi MM, Leclerc K, Huo J, et al. Ecto-5'-nucleotidase (CD73) regulates bone formation and remodeling during intramembranous bone repair in aging mice. Tissue Cell. 2017;49(5):545\u201351.","journal-title":"Tissue Cell"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02961-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-022-02961-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02961-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T06:07:09Z","timestamp":1670566029000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-022-02961-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2961"],"URL":"https:\/\/doi.org\/10.1186\/s13075-022-02961-0","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"assertion":[{"value":"1 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All protocols followed internationally recognized guidelines and were approved by the NYU SoM Institutional Animal Care and Use Committee. Human bone marrow was obtained from surgical specimens (knee replacement) that would have otherwise been discarded. This use of deidentified tissue is exempt from Institutional Review Board approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Dr. Ane Larranaga-Vera, Dr. Kiran Toti, Mr. James Flatow, Ms. Alexandra Haraczy, Mr. Eugene Warnick, Mr. Harsha Rao, Dr. Zhan-Guo Gao, Ms. Sarah Sussman, Dr. Philipp Leucht, and Dr. Kenneth Jacobson declare that they have no competing interests. Dr. Aranzazu Mediero and Dr. Bruce Cronstein have a patent on use of Adenosine A1 receptor antagonists and A2A receptor agonists for the promotion of bone regeneration pending. Dr. Cronstein is a co-founder of Regenosine, a startup formed to exploit the utility of adenosine receptor agonists for the treatment of osteoarthritis and other related diseases.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"265"}}